Back to GOLDMAN SACHS GROUP INC GOLDMAN SACHS GROUP INC

TEVATEVA
17 quarters

Position history for GOLDMAN SACHS GROUP INCGOLDMAN SACHS GROUP INC's holdings in TEVA PHARMACEUTICAL INDS LTD

Yes. Goldman Sachs holds 6,129,240 shares of TEVA (Teva Pharmaceutical Industries), worth $207.7M, as of its Q2 2026 13F filing. It increased the position by 1,302,995 shares (+27.0%) from Q1 2026. Goldman Sachs has held TEVA in every 13F on record since Q2 2022, 17 quarterly filings.

Current Value

$207.7M

Current Shares

6.1M

Total Value Change

+$171.4M

Total Shares Change

+1.3M

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Increased
6.1M
+27.0%
$207.7M0.0%$33.88
38
2026-Q1
Decreased
4.8M
-17.9%
$145.4M0.0%$30.12
0
2025-Q4
Increased
5.9M
+15.6%
$183.5M0.0%$31.21
35
2025-Q3
Increased
5.1M
+4.2%
$102.7M0.0%$20.20
31
2025-Q2
Increased
4.9M
+23.1%
$81.8M0.0%$16.76
36
2025-Q1
Increased
4M
+12.8%
$60.9M0.0%$15.37
33
2024-Q4
Decreased
3.5M
-15.4%
$77.5M0.0%$22.04
0
2024-Q3
Decreased
4.2M
-3.1%
$74.9M0.0%$18.02
0
2024-Q2
Increased
4.3M
+21.1%
$69.7M0.0%$16.25
35
2024-Q1
Decreased
3.5M
-6.9%
$50M0.0%$14.11
0
2023-Q4
Decreased
3.8M
-14.3%
$39.7M0.0%$10.44
0
2023-Q3
Decreased
4.4M
-2.4%
$45.3M0.0%$10.20
0
2023-Q2
Decreased
4.5M
-2.3%
$34.3M0.0%$7.53
0
2023-Q1
Decreased
4.7M
-12.8%
$41.2M0.0%$8.85
0
2022-Q4
Increased
5.3M
+2.3%
$48.7M0.0%$9.12
30
2022-Q3
Increased
5.2M
+8.3%
$42.1M0.0%$8.07
32
2022-Q2
First report
4.8M
-
$36.2M0.0%$7.52
0

Other major holders of TEVA: BlackRock, Inc., Capital Research Global Investors

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used